Abstract
The classical neuroleptic drugs haloperidol and pimozide have a strong disruptive effect on the acquisition of conditioned avoidance responding (CAR), yet have relatively little impact on the performance of previously acquired responses. Separate experiments compared the effects of haloperidol, two atypical neuroleptics, thioridazine and clozapine, and a substituted benzamide, metoclopramide, on one-way avoidance by rats. Thioridazine (10–50 mg/kg) and clozapine (1.25–10.0 mg/kg) disrupted both acquisition and performance of CAR. In contrast, haloperidol (0.075–0.150 mg/kg) and metoclopramide (5.0–7.5 mg/kg) completely blocked the acquisition of CAR, yet initially produced only a slight disruption in the performance of a previously acquired response. The ineffectiveness of the atypical neuroleptics in producing a complete disruption of acquisition of CAR may be due to the anticholinergic properties of these drugs. Alternatively, the differences between metoclopramide and the atypical neuroleptics may be due to a preferential effect of metoclopramide on striatal or amygdaloid dopamine neurotransmission. These results suggest that caution should be exercised in using CAR as an animal model for assessing the antipsychotic potential of new pharmacological agents.
Similar content being viewed by others
References
Altar CA, Wasley AM, Neale RF, Stone GA (1986) Typical and atypical antipsychotic occupancy of D2 and S2 receptors: An autoradiographic analysis in rat brain. Brain Res Bull 16:517–525
Anisman H, Irwin J, Zacharko RM, Tombaugh TN (1982) Effects of dopamine receptor blockade on avoidance performance: assessment of effects on cue-shock and response-outcome associations. Behav Neural Biol 36:280–290
Arnt J (1982) Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade. Acta Pharmacol Toxicol 51:321–329
Ashford J, Jones BJ (1976) The effects of intra-amygdaloid injections of 6-hydroxydopamine on avoidance responding in rats. Br J Pharmacol 56:225–261
Bateman DN, Rawlins MD, Simpson JM (1985) Extrapyramidal reactions with metoclopramide. Br Med J 291:930–932
Beninger RJ (1989) The role of serotonin and dopamine in learning to avoid aversive stimuli. In: Archer T, Nilsson L-G (eds) Per-spectives in aversively motivated behavior. Eribaum, Hillsdale NJ (in press)
Beninger RJ, Phillips AG, Fibiger HC (1983) Prior training and intermittent retraining attenuate pimozide-induced avoidance deficits. Pharmacol Biochem Behav 18:619–624
Blackburn JR, Phillips AG, Fibiger HC (1987) Metoclopramide-induced disruption of conditioned avoidance responding. Can Psychol [Abstr] 28:42
Blaha CD, Lane RF (1987) Chronic treatment with classical and atypical antipsychotic drugs differentially decreases dopamine release in striatum and nucleus accumbens in vivo. Neurosci Lett 78:199–204
Borenstein P, Bles G (1965) Effects cliniques et electoencephalographiques du metoclopramide en psychiatrie. Therapie 20:975–995
Chiodo LA, Bunney BS (1985) Possible mechanisms by which repeated clozapine administration differentially affects the activity of two subpopulations of midbrain dopamine neurons. J Neurosci 5:2539–2544
Cooper BR, Breese GR, Grant LD, Howard JL (1973) Effects of 6-hydroxydopamine treatments on active avoidance responding: evidence for involvement of brain dopamine. J Pharmacol Exp Ther 185:358–370
Davidson AB, Weidley E (1976) Differential effects of neuroleptic and other psychotropic agents on acquisition of avoidance in rats. Life Sci 18:1279–1284
Fibiger HC, Phillips AG, Zis AP (1974) Deficits in instrumental responding after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection. Pharmacol Biochem Behav 2:87–96
Fibiger HC, Zis AP, Phillips AG (1975) Haloperidol-induced disruption of conditioned avoidance responding: attenuation by prior training or by anticholinergic drugs. Eur J Pharmacol 30:309–314
Gerlach J, Tharsen K, Fog R (1975) Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients. Psychopharmacology 46:341–350
Harrington RA, Hamilton CW, Brogden RN, Linkewich JA, Romankiewicz JA, Heel RC (1983) Metoclopramide: an updated review of its pharmacological properties and clinical use. Drugs 25:451–494
Howard JL, Large BT, Wedley S, Pullar IA (1978) The effects of standard neuroleptic compounds on the binding of 3H-spiroperidol in the striatum and mesolimbic system of the rat in vitro. Life Sci 23:599–604
Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226:462–468
Irwin S (1961) Correlation in rats between the locomotor and avoidance suppressant potencies of eight phenothiazine tranquilizers. Arch Int Pharmacodyn Ther 132:279–286
Janssen PAJ, Niemegeers CJE, Schellekens KHL (1965) Is it possible to predict the clinical effects of neuroleptic drugs (major tranquilizers) from animal data? I. “Neuroleptic activity spectra” for rats. Arzneimittelforschung 15:104–117
Klawans HL (1968) The pharmacology of parkinsonism (a review). Dis Nerv Syst 29:805–816
Klein DF, Gittelman R, Quitkin F, Rafkin A (1980) Diagnosis and treatment of psychiatric disorders, 2nd edn. Williams and Williams, Baltimore
Koob GF, Simon H, Herman JP, Le Moal M (1984) Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems. Brain Res 303:319–329
Lane RF, Blaha CD (1987) Acute thioridazine stimulates mesolimbic but not nigrostriatal dopamine release: Demonstration by in vivo electrochemistry. Brain Res 408:317–320
Lenard JG, Beer B (1975) Relationship of brain levels of norepinephrine and dopamine to avoidance behavior in rats after intraventricular administration of 6-hydroxydopamine. Pharmacol Biochem Behav 3:895–899
Ljungberg T, Ungerstedt U (1979) Evidence that the different properties of haloperidol and clozapine are not explained by differences in anticholinergic potency. Psychopharmacology 60:303–307
Ljungberg T, Ungerstedt U (1985) A rapid and simple behavioural screening method for simultaneous assessment of limbic and striatal blocking effects of neuroleptic drugs. Pharmacol Biochem Behav 23:479–485
Nakra B, Bond AJ, Lader MH (1975) Comparative psychotropic effects of metoclopramide and prochlorperazine in normal subjects. J Clin Pharmacol 15:449–454
Petty F, Mott J, Sherman AD (1984) Potential locus and mechanism of blockade of conditioned avoidance responding by neuroleptics. Neuropharmacology 23:73–78
Phillips AG, Fibiger HC (1979) Decreased resistance to extinction after haloperidol: implications for the role of dopamine in reinforcement. Pharmacol Biochem Behav 10:751–760
Posluns D (1962) An analysis of chlorpromazine-induced suppression of the avoidance response. Psychopharmacologia 3:361–373
Robertson A, MacDonald C (1984) Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy. Pharmacol Biochem Behav 21:97–101
Robertson A, MacDonald C (1985) Opposite effects of sulpiride and metoclopramide on amphetamine-induced stereotypy. Eur J Pharmacol 109:81–89
Setler P, Sarua H, McKenzie G (1976) Differential attenuation of some effects of haloperidol in rats given scopolamine. Eur J Pharmacol 39:117–126
Sherman AD, Petty F, Sacquitne JL (1982) Regional aspects of the delay of acquisition conditioned avoidance responding by chlorpromazine. Life Sci 30:1811–1815
Snyder S, Greenberg D, Yamamura HI (1974) Antischizophrenic drugs and brain cholinergic receptors. Arch Gen Psychiatry 31:58–61
Stanley M, Lautin A, Rotrosen J, Gershon S, Kleinberg D (1980) Metoclopramide: antipsychotic efficacy of a drug lacking potency in receptor models. Psychopharmacology 71:219–225
Tamminga CA (1983) Atypical neuroleptics and novel antipsychotic drugs. In: Coyle JT, Enna SJ (eds) Neuroleptics: neurochemical, behavioral and clinical perspectives. Raven Press, New York, pp 281–295
White FJ, Wang RY (1983) Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. Science 221:1054–1057
Wise RA, Spindler J, DeWit H, Gerber GJ (1978) Neuroleptic-induced “anhedonia” in rats: pimozide blocks reward quality of food. Science 201:262–264
Zis AP, Fibiger HC, Phillips AG (1974) Reversal by L-dopa of impaired learning due to destruction of the dopaminergic nigroneostriatal bundle. Science 185:960–962
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blackburn, J.R., Phillips, A.G. Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic drugs. Psychopharmacology 98, 453–459 (1989). https://doi.org/10.1007/BF00441941
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00441941